intoDNA

📍 Krakow, Poland🗓 Founded 2017👥 46 employees💰 Last funded Sep 2025
intoDNA is a growing biotech start-up that offers an end-to-end process for DNA break detection with STRIDE, its proprietary technology. It is an innovative technology that outcompetes any other tools in its sensitivity, providing a reliable measure of DNA damage at an individual lesion level.STRIDE has been successfully used by leaders in the biotechnology and pharmaceutical industries and renowned academic groups in DNA damage response, cancer immunotherapy, and nuclear medicine fields.
5
Total investors
1
Early stage
2
Mid stage
2
Late stage
2017
Founded
Investor geography3 countries
Poland
3
United Kingdom
1
United States
1
Investor activity2019–2025 · investors recorded per year
20191202012021120252
Recent (last 2y)Earlier
Frequently asked questions
Who invested in intoDNA?
intoDNA has 5 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage and 2 late-stage investors.
When did intoDNA last raise funding?
The most recent investment in intoDNA recorded on gritt.io was in September 2025.
When was intoDNA founded?
intoDNA was founded in 2017.
What industry is intoDNA in?
intoDNA operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is intoDNA based?
intoDNA is headquartered in Krakow, Poland.